Cygnal Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Cygnal Therapeutics's estimated annual revenue is currently $9.3M per year.
- Cygnal Therapeutics's estimated revenue per employee is $155,000
- Cygnal Therapeutics has 60 Employees.
- Cygnal Therapeutics grew their employee count by 13% last year.
- Cygnal Therapeutics currently has 1 job openings.
What Is Cygnal Therapeutics?
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformￃﾢ￢ﾀﾞￂﾢ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.keywords:N/A